DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹850 Cr | ₹527 Cr | ₹445 Cr | ₹1,265 Cr | ₹624 Cr |
What is the latest Short Term Provisions ratio of DIVIS LABORATORIES ?
| Year | Short Term Provisions |
|---|---|
| Mar2025 | ₹850 Cr |
| Mar2024 | ₹527 Cr |
| Mar2023 | ₹445 Cr |
| Mar2022 | ₹1,265 Cr |
| Mar2021 | ₹624 Cr |
How is Short Term Provisions of DIVIS LABORATORIES Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹850 Cr | 61.29 | |
| Mar2024 | ₹527 Cr | 18.43 | |
| Mar2023 | ₹445 Cr | -64.81 | |
| Mar2022 | ₹1,265 Cr | 102.56 | |
| Mar2021 | ₹624 Cr | - | |
Compare Short Term Provisions of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹179,300.1 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,610.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,649.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹114,469.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,955.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
| MANKIND PHARMA | ₹99,864.1 Cr | -0.6% | 11% | -1.8% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 0.8% |
9.5% |
4.2% |
| SENSEX | 1.1% |
-2.1% |
-6.4% |
You may also like the below Video Courses